![John Sprague](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Sprague
Finanzdirektor/CFO bei
CELULARITY INC.
Vermögen: - $ am 31.05.2026
Profil
John M.
Sprague is currently Chief Financial Officer at Celularity, Inc. since 2026.
Formerly, Mr. Sprague was Chief Financial Officer & Treasurer at T2 Biosystems, Inc. from 2018 to 2025, Finance Manager-North American Core Imaging at GE Healthcare, Inc. from 2011 to 2017, Chief Financial Officer at Caliber Imaging & Diagnostics, Inc. from 2017 to 2018, Chief Financial Officer at Xcellerex, Inc., and Senior Manager at Deloitte & Touche LLP from 1980 to 1992.
Mr. Sprague completed undergraduate studies at Wallace E Carroll School of Management in 1980.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.01.2025 | 141 ( 0% ) | 0 $ | 31.05.2026 |
Aktive Positionen von John Sprague
| Unternehmen | Position | Beginn |
|---|---|---|
| CELULARITY INC. | Finanzdirektor/CFO | 27.02.2026 |
Ehemalige bekannte Positionen von John Sprague
| Unternehmen | Position | Ende |
|---|---|---|
| T2 BIOSYSTEMS, INC. | Finanzdirektor/CFO | 03.04.2025 |
| CALIBER IMAGING & DIAGNOSTICS, INC. | Finanzdirektor/CFO | 01.01.2018 |
GE Healthcare, Inc.
 GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Finanzdirektor/CFO | 01.01.2017 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Corporate Officer/Principal | 01.01.1992 |
Xcellerex, Inc.
 Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Offers contract services for bioprocess development and manufacturing | Finanzdirektor/CFO | - |
Ausbildung von John Sprague
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
93
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Xcellerex, Inc.
Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Offers contract services for bioprocess development and manufacturing | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
Caliber Imaging & Diagnostics, Inc.
 Caliber Imaging & Diagnostics, Inc. Medical SpecialtiesHealth Technology Manufactures noninvasive diagnostic confocal imagers | Health Technology |
T2 Biosystems, Inc.
 T2 Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
GE Healthcare, Inc.
GE Healthcare, Inc. Medical SpecialtiesHealth Technology Manufactures and retails diagnostic imaging & medical equipment | Health Technology |
Wallace E Carroll School of Management
 Wallace E Carroll School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celularity, Inc.
 Celularity, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biotechnology company that discovers cancer sub-types and therapeutic options for cancer patients | Commercial Services |
